Cholesterol-lowering drugs as cardioprotective agents
- 21 December 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (21) , I27-I32
- https://doi.org/10.1016/0002-9149(92)90262-w
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoproteinAtherosclerosis, 1990
- Beyond CholesterolNew England Journal of Medicine, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic AcidActa Medica Scandinavica, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of internal medicine (1960), 1988
- Fibric acids: Effects on lipids and lipoprotein metabolismThe American Journal of Medicine, 1987
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975